The QualityStocks Daily Monday, March 11th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(ASLN) $1.6300 +160.80%

MarketClub Analysis(PIK) $4.8700 +80.37%

Early Bird(BALY) $13.6400 +28.44%

The QualityStocks Daily Stock List

Aslan Pharmaceuticals (ASLN)

TradersPro, StockMarketWatch, QualityStocks, MarketBeat, BUYINS.NET, Schaeffer's, MarketClub Analysis, InvestorsUnderground and FreeRealTime reported earlier on Aslan Pharmaceuticals (ASLN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aslan Pharmaceuticals Limited (NASDAQ: ASLN) (FRA: 7A9) is a clinical-stage biopharmaceutical firm focused on immunology, which is centered on the development of treatments of novel therapies.

The firm has its headquarters in Singapore and was incorporated in 2010 by Jeffrey Tomlinson, Mark McHale and Carl Aslan Jason Morton Firth. It operates in the health care sector under the biotech and pharma sub-industry. The firm targets ailments that are prevalent in Asia and orphan indications in Europe and the United States.

The company is party to a joint venture with Bukwang Pharmaceutical Co. Ltd, which entails the development of immune-oncology therapeutics that target the AhR pathway. It also has partners, which include CSL Limited, Array BioPharma and Almirall, and is focused on developing therapies that transform the lives of patients.

The enterprise’s pipeline is made up of a first-in-class monoclonal therapy dubbed ASLAN004 which is indicated for the treatment of atopic dermatitis and asthma, among other immunology indications. Atopic dermatitis, commonly known as eczema, makes an individual’s skin itchy and red. On the other hand, asthma causes a patient’s airways to swell and narrow, which makes it harder to breathe and results in coughing or wheezing. In addition to this, it also develops a small-molecule dihydroorotate dehydrogenase inhibitor known as ASLAN003, indicated for the treatment of various autoimmune conditions. Furthermore, the enterprise also produces an AhR antagonist and varlitinib.

The company’s ASLAN004 formulation, which recently concluded its phase 1 study and is set to proceed to phase 2, has shown remarkable effectiveness and safety. Its success will benefit patients with atopic dermatitis and bring in more investors into the firm, which will be good for the company’s growth.

Aslan Pharmaceuticals (ASLN), closed Monday's trading session at $1.63, up 160.8%, on 25,317,197 volume. The average volume for the last 3 months is 178,893 and the stock's 52-week low/high is $0.392/$4.69.

LM Funding America (LMFA)

StockMarketWatch, MarketClub Analysis, TradersPro, QualityStocks, Marketbeat.com, BUYINS.NET, TraderPower, MarketBeat, StocksEarning, PennyStockProphet, Buzz Stocks, HotOTC, InvestorPlace, OTCtipReporter, Penny Stock, WealthMakers, Profitable Trader Authority, StockOnion, The Online Investor and Penny Pick Finders reported earlier on LM Funding America (LMFA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LM Funding America Inc. (NASDAQ: LMFA) (FRA: 1YJA) is a specialty finance firm that operates through its LM Funding LLC subsidiary. The firm offers funding to non-profit community associations located in Florida as well as in the states of Illinois, Colorado and Washington.

LM Funding America Inc. serves consumers throughout the U.S. and was founded on January 14, 2008. The firm has its headquarters in Tampa, Florida and was established by Carollinn Gould.

The company provides nonprofit community associations a range of financial products that can be customized to meet each association’s financial needs. The firm’s products include the new neighbor guaranty and original product. The original product is comprised of offering funding to associations by buying their purchasing rights under delinquent accounts that have been picked by the associations arising from association assessments that have not been paid. On the other hand, LM Funding America Inc. buys delinquent accounts on different terms that have been tailored to suit an association’s needs, under its new neighbor guaranty program. The firm also offers medical insurance products for international travelers.

LM Funding America Inc. recently launched its IPO through its blank check company LMF Acquisition Opportunities. The firm plans to target businesses in the financial services industry and related sectors, with enterprise values between $250-$500 million. This move will not only boost the parent company’s growth but also allow significant expansion in the sector, which will most likely draw in investors.

LM Funding America (LMFA), closed Monday's trading session at $0.5655, up 30.2695%, on 6,048,260 volume. The average volume for the last 3 months is 5.555M and the stock's 52-week low/high is $1.632894/$8.22.

NaturalShrimp Incorporated (SHMP)

QualityStocks, PennyPickGains, Pennystockmania, WallstreetSurfers, ThePennyPicks, SmallCapVoice, PoliticsAndMyPortfolio, Wall Street Mover, TopPennyStockMovers, StocksEarning, MarketClub Analysis and Daily Wealth reported earlier on NaturalShrimp Incorporated (SHMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, NaturalShrimp Incorporated produces naturally-grown shrimp in the U.S. and worldwide. The Company has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals. Its systems are self-contained, saltwater production facilities. These facilities will produce Pacific White Shrimp anywhere in the world. NaturalShrimp is based in Addison, Texas.

The Company’s production facility is outside of San Antonio, Texas. Its European partner has built a production facility in Medina del Campo, Spain. Expansion plans include domestic and global production facilities and distribution channels. The Company’s state-of-the-art production facilities will use a shrimp grow-out process projected to produce 6,000 pounds of fresh shrimp weekly upon reaching full production.

The design of the NaturalShrimp Production System will be to produce shrimp at a harvest size of eighteen to twenty-two, head-on shrimp per pound in a period of 24 weeks or less. Furthermore, NaturalShrimp has developed production methods which minimize the transferring of shrimp from tank to tank. As a result, this decreases mortality rates and labor costs. The environmentally-controlled building and automated tank systems will allow for fresh, naturally grown, year-round shrimp production.

NaturalShrimp’s patented Vibrio Suppression Technology effectively eliminates water-borne bacteria and other harmful organisms. In addition, it keeps ammonia at safe concentration levels. Closed-System Shrimp Farming is inherently superior because it is sustainable, ecologically friendly, and also cost-effective. The potential to commercially scale this solution represents a significant competitive advantage for the Company.

NaturalShrimp Incorporated (SHMP), closed Monday's trading session at $0.0129, up 19.4444%, on 14,219,737 volume. The average volume for the last 3 months is 192,993 and the stock's 52-week low/high is $0.01/$0.082.

Scworx Corp. (WORX)

QualityStocks, StockMarketWatch, MarketClub Analysis, BUYINS.NET, Jet-Life Penny Stocks, InvestorPlace, TradersPro and The Online Investor reported earlier on Scworx Corp. (WORX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Scworx Corp. (NASDAQ: WORX) is engaged in the provision of software solutions for managing foundational business applications for health care providers in the U.S.

The firm has its headquarters in New York and was incorporated in 2012 by Marc C. Schessel. It operates in the consumer sector, under the consumer discretionary services industry and the leisure facilities and services sub-industry. The firm, which was known as Alliance MMA Inc., serves consumers in New York.

The enterprise provides different software services and solutions like a closed loop scanning solution known as ScanWorx; contract management, a module which helps healthcare providers in establishing contract management systems, rebate management and offers care to patients; CDM (Charge Description Master Management) module, which helps health care providers to integrate CDM data into the workflow of the purchasing system of a hospital; electronic medical record management; and virtualized item master automation, expansion and file repair.

Additionally, the firm also provides a ticketing platform that caters to the mixed martial arts industry dubbed CageTix. This is in addition to being involved in the sale of self-swab test kits for the coronavirus as well as personal protective equipment. It sells its services and solutions to health systems and hospitals via reseller and distribution partnerships.

The company recently appointed a new individual to its board of directors who has decades of experience in healthcare and will help the firm form partnerships with large hospital groups, which it targets. This is bound to bring in more investors into the firm, which will boost growth.

Scworx Corp. (WORX), closed Monday's trading session at $1.875, up 16.4596%, on 1,710,049 volume. The average volume for the last 3 months is 75,461 and the stock's 52-week low/high is $1.14/$14.40.

Graphite One (GPHOF)

QualityStocks and TradersPro reported earlier on Graphite One (GPHOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Graphite One, Inc. (OTCQX: GPHOF) (CVE: GPH) (FRA: 2JCA) is a mineral exploration firm that is focused on exploring for, acquiring and evaluating graphitic mineral properties.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2006, on March 16th. Prior to its name change in February 2019, the firm was known as Graphite One Resources Inc. It operates as part of the other industrial metals and mining industry, under the renewable energy and basic materials sectors. The firm serves clients and consumers in Canada.

The company is focused on the production of a range of graphite applications, as well as on the production of anode material for the Li-ion electric car battery market and energy storage systems market.

The enterprise holds interest in the Graphite Creek property, which comprises of 176 mining claims which cover an area of about 9,580 hectares situated on Alaska’s Seward Peninsula. Through its subsidiary, the enterprise is evaluating resources on its Graphite Creek property, which is situated roughly 60km north of Nome, Alaska. This project is seen as a vertically integrated enterprise for mining, processing and manufacturing CSG (coated spherical graphite). The enterprise is also evaluating the establishment of a manufacturing facility for graphite products using graphite extracted from this property.

The firm recently announced its latest drill results from a 2021 field program conducted in its Creek project. The results demonstrate the presence of high grades of graphitic carbon, with its CEO noting that this would offer it the opportunity to grow its reserve and resource estimates. This will positively influence the firm’s revenues as well as its growth.

Graphite One (GPHOF), closed Monday's trading session at $0.7035, up 15.3279%, on 209,344 volume. The average volume for the last 3 months is 339,233 and the stock's 52-week low/high is $0.554/$1.34.

Unusual Machines (UMAC)

We reported earlier on Unusual Machines (UMAC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Unusual Machines Inc. (NYSE American: UMAC) is a development stage technology firm focused on designing, manufacturing, and selling ultra-low latency video goggles for drone pilots.

The firm has its headquarters in San Juan, Puerto Rico and was incorporated in 2019, on July 11th. Prior to its name change in July 2022, the firm was known as AerocarveUS Corp. It operates as part of the shell companies industry, under the financial services sector. The firm serves consumers around the globe, with a focus on those in the United States.

The company’s primary objective is to acquire firms involved in the drone industry to continue to focus on leveraging and growing the market share in the consumer and hobbyist sectors of drone products. Its scope of interest focuses on firms developing first-person view (FPV) drone technology products that can be used for recreation, entertainment as well as competitive racing purposes. The company’s other objective is to explore potential expansion into new sub-markets such as public safety and drone delivery functions.

The enterprise seeks to be the dominant tier 1 parts supplier to the fast growing multi-billion dollar U.S. drone industry. The global drone accessories market is currently valued at $17.5B and is set to top $115B by 2032.

The company recently concluded its acquisitions of Rotor Riot LLC, an e-commerce marketplace that serves drone enthusiasts, and Fat Shark Holdings Limited, a company that designs and manufactures ultra-low latency first-person-view (FPV) goggles. This move will allow Unusual Machines to expand its consumer base while also bolstering its overall market position.

Unusual Machines (UMAC), closed Monday's trading session at $2.41, off by 12.3636%, on 4,740,403 volume. The average volume for the last 3 months is 111,368 and the stock's 52-week low/high is $2.31/$5.54.

FSD Pharma Inc. (HUGE)

QualityStocks, Schaeffer's, BUYINS.NET, StockMarketWatch, MarketClub Analysis, BioMedWire, StockEarnings, PsychedelicNewsWire, Penny Dreamers, InvestorPlace, CFN Media Group, bullseyeoptiontrading and AwesomeStocks reported earlier on FSD Pharma Inc. (HUGE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has submitted a Clinical Trial Application (“CTA”) for its planned phase-1b clinical trial. According to the announcement, the trial will focus on evaluating the safety and efficacy of unbuzzd(TM) in healthy volunteers in an induced state of alcohol intoxication. The application is the first step in receiving approval to begin the trial; the application will be reviewed by an Australian human ethics review committee (“HREC”). Pending approval, the company anticipates beginning to recruit volunteers in April. A dietary supplement product under development for potential marketing in the United States, unbuzzd(TM) is a fortified oral liquid formula containing natural ingredients, vitamins and other food supplements designed to enhance cognition and replenish cofactors needed for alcohol metabolism; the company noted that the formula has potential to accelerate the rate of alcohol metabolism in the body, restore mental alertness and improve cognition post-alcohol consumption.

“This marks the culmination of several months of intense work by the FSD team and by our expert advisors, conceptualizing and designing this meaningful clinical trial to assess the safety and efficacy of this exciting product on people who drink alcohol,” said FSD Pharma vice president of scientific and clinical affairs Dr. Andrzej Chruscinski in the press release. “We look forward to working closely and swiftly with our Australian partners and the ethics committee on this project.”

To view the full press release, visit https://ibn.fm/B5fYv

About FSD Pharma Inc.

FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) (“Lucid-MS”). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma has also licensed unbuzzd(TM), a proprietary formulation of natural ingredients, vitamins and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption for use in the consumer recreational sector, to Celly Nutrition Corp; FSD is entitled to a royalty on the revenue generated by Celly Nu from sales of products created using the technology rights granted under the licensing agreement. FSD continues its R&D activities to develop novel formulations for alcohol misuse disorders and continues the development of such treatments for use in the healthcare sector. FSD Pharma also maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property. For more information about the company, please visit www.FSDPharma.com.

FSD Pharma Inc. (HUGE), closed Monday's trading session at $0.7811, off by 3.5679%, on 115,182 volume. The average volume for the last 3 months is 22.896M and the stock's 52-week low/high is $0.72/$2.10.

Tilray Brands Inc. (TLRY)

InvestorPlace, Schaeffer's, StocksEarning, StockEarnings, The Street, QualityStocks, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, BUYINS.NET, Zacks, Investopedia, CFN Media Group, CNBC Breaking News, Early Bird, The Street Report, Daily Profit, INO Market Report, StreetAuthority Daily, Inside Trading, The Rich Investor, Trading Concepts, Trading For Keeps, Tip.us, FreeRealTime, Top Pros' Top Picks, InvestmentHouse, InsiderTrades, Eagle Financial Publications, Investors Alley, Investment House, Outsider Club, wyatt research newsletter, Wealth Daily, VectorVest, TheTradingReport, The Night Owl, StrategicTechInvestor, MarketClub, Rick Saddler, InvestorsObserver Team, Money Morning, AllPennyStocks, Marketbeat.com, Louis Navellier, Jim Cramer, Jason Bond, InvestorsUnderground and Stock Up Featured reported earlier on Tilray Brands Inc. (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent study suggests a potential link between cannabis use and reduced instances of subjective cognitive decline (SDC), wherein individuals who incorporate cannabis into their routines, whether for medical or recreational purposes, report experiencing less memory impairment and confusion than nonusers.

Published in the “Current Alzheimer Research” Journal, the study’s significance lies in its departure from prior research that has often associated subjective cognitive decline with a higher risk of dementia in later life. The findings challenge conventional assumptions about the cognitive impacts of THC, the primary psychoactive component of marijuana.

The research, conducted by scholars from SUNY Upstate Medical University, examines various facets of marijuana use and its association with SCD among older and middle-aged adults in the United States. Unlike previous studies, which primarily focused on heavy marijuana consumption’s adverse effects on mental performance, this study delved into the nuanced relationship between marijuana use frequency, reasons for consumption, method of administration and subjective cognitive decline.

The researchers obtained insights from respondents 45 years of age and older in 14 states as well as Washington, D.C., by examining data from the 2021 Behavioral Risk Factor Surveillance System (BRFSS). The study, which included 4,744 valid responses on SCD, investigated the use of cannabis by participants, including how often they used it, why they used it (medically, recreationally, or both), and how they consumed it (smoking, ingesting it, vaporizing it, etc.).

The study disproved assumptions regarding the negative effects of cannabis use on cognition by showing that recreational marijuana usage was highly linked to a decreased risk of SCD in contrast to nonusers. The researchers proposed several hypotheses to explain these findings, including the potential role of cannabis in improving sleep quality and reducing stress levels, both of which are implicated in cognitive function.

However, the study also identified some mixed results. While certain consumption methods, particularly smoking, were associated with a higher prevalence of SCD, the relationship between marijuana use frequency and subjective cognitive decline was not statistically significant. Moreover, the study highlighted the prevalence of SCD among individuals using marijuana for medical or combined medical and nonmedical reasons, hinting at the complexity of the relationship between marijuana use motives and cognitive outcomes.

Despite shedding new light on the potential cognitive benefits of marijuana use, the study acknowledges several limitations. Self-reported data, potential underreporting or misreporting of cannabis use, and the lack of geographical diversity in the sample raise questions about the study’s generalizability and reliability.

In conclusion, while the study challenges prevailing beliefs about the cognitive impacts of cannabis, it underscores the need for further research to elucidate the underlying mechanisms and potential risks associated with cannabis consumption. By considering multiple factors, including reasons for use, future studies can provide a more nuanced understanding of cannabis’s effects on cognitive health.

For now, users of licensed marijuana products from various companies such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) can take comfort in the fact that they may not face any major risk of cognitive decline if they use cannabis products in moderation.

Tilray Brands Inc. (TLRY), closed Monday's trading session at $1.67, off by 1.7647%, on 10,327,499 volume. The average volume for the last 3 months is 822,400 and the stock's 52-week low/high is $1.50/$3.40.

Aurora Cannabis Inc. (ACB)

InvestorPlace, Schaeffer's, MarketBeat, StocksEarning, MarketClub Analysis, The Street, Trades Of The Day, QualityStocks, StockEarnings, Daily Trade Alert, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Kiplinger Today, StockMarketWatch, CFN Media Group, Investopedia, Stock Up Featured, Profit Trends, BUYINS.NET, BlackSwanAlert, StreetAuthority Daily, The Rich Investor, Jim Cramer, Early Bird, Investors Alley, Cannabis Financial Network News, Wall Street Window, CNBC Breaking News, Daily Profit, Tradespoon, Inside Trading, Outsider Club, TheTradingReport, Zacks, The Wealth Report, Market Intelligence Center, Technology Profits Daily, Money and Markets and Top Pros' Top Picks reported earlier on Aurora Cannabis Inc. (ACB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New research has challenged the stereotype that cannabis users are lazy and inactive. The research was conducted by investigators at The Ohio University and the University of Texas at Dallas and involved more than 2,500 adults who took part in the National Longitudinal Study of Adolescent to Adult Health in the period between 2016 to 2018.

This research is the first to examine the link between the use of e-cigarettes, cannabis and physical activity.

The investigators found that the use of e-cigarettes and cannabis among participants forecasted their penchant for exercises such as walking, with cannabis users walking more times in a week followed by nonusers, e-cigarette users and, lastly, individuals who used both.

The researchers theorized cannabis users walking more often than nonusers could be because some individuals used marijuana to increase their enjoyment of and motivation for exercise or the concentration of cannabis users in urban areas. Individuals who live in large cities in America, which are often states where recreational and medical cannabis are legal, also tend to walk more and use public transport.

The investigators added that their observation was only significant after covariates were accounted for, noting that no considerable differences in general exercise or strength training was observed between groups.

In their report, the scientists highlighted that their findings challenged the stereotype that cannabis users weren’t as active as their nonuser counterparts and highlighted that the use of cannabis wasn’t significantly associated with engagement in any particular physical activity.

The research’s findings were reported in the “Preventive Medicine Reports” journal.

Using marijuana to increase enjoyment was observed in another study, which determined that consuming cannabis before exercise could enhance runner’s high and increase enjoyment. Separate research published last year also found that participants who used marijuana during their runs experienced greater feelings of positive affect, less negative affect, enjoyment, dissociation and tranquility, as well as more runner’s high symptoms.

Marijuana’s positive effects from the above study are consistent with the findings of another study, which determined that individuals who used cannabis to enhance their workouts tended to get a healthier amount of exercise in. Another study published in 2020 also found that older individuals who used marijuana were more likely to take part in physical activity.

In 2021, researchers also published findings from another study focused on busting stereotypes, which found that frequent consumers of cannabis were more likely to be physically active in comparison to nonusers.

As more scientific data becomes available about the state-legal marijuana products from various companies such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), many of the stereotypes and myths about this substance are likely to be gradually dispelled.

Aurora Cannabis Inc. (ACB), closed Monday's trading session at $3.02, off by 5.0314%, on 834,764 volume. The average volume for the last 3 months is 589,763 and the stock's 52-week low/high is $2.855/$11.50.

Compass Minerals International Inc. (CMP)

SmarTrend Newsletters, QualityStocks, MarketBeat, The Online Investor, DividendStocks, Daily Trade Alert, Trades Of The Day, Marketbeat.com, InvestorPlace, The Street, Kiplinger Today, MiningNewsWire, Zacks, StreetAuthority Daily, StreetInsider, Schaeffer's, All about trends, MarketClub Analysis, Barchart, BUYINS.NET, CRWEFinance, Daily Market Beat, Wyatt Investment Research, Daily Wealth, Top Pros' Top Picks, InsiderTrades, The Stock Dork and Insider Wealth Alert reported earlier on Compass Minerals International Inc. (CMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Currently, the controlled release fertilizer market in North America is valued at $570.1 million. With a compounded annual growth rate of 7.91%, it is expected that the value of this market will have reached $900.4 million by 2030. This is according to the recent Market Share Analysis report on the controlled release fertilizer market in North America. The study period runs from 2016, with forecasts through 2030.

The largest segment under this market by type of coating is polymer-coated fertilizers, which supply the important secondary and primary nutrients to the crops. This eliminates the need to apply the fertilizer multiple times.

The biggest segment by type is CRF urea, which works by releasing nitrogen gradually. This fertilizer prevents nitrogen mineralization, which degrades the quality of the soil.

Based on country, the United States makes up almost 70% of the agricultural crop total area. The U.S. is among the major fertilizer producers in North America. During the study period, this particular fertilizer market grew by almost 71%. This can mainly be attributed to the wide practice of precision farming across the country.

A crucial component of this particular faming concept is using the right nutrient dosage for crops at the optimal time. This makes controlled-release fertilizers very important.

With regard to type of crop, field crops make up the larger share of the fertilizers market in North America (82.4%), primarily because of the large cultivation area in the region. The remaining share of the market is comprised of turfs and ornamentals.

Coated controlled-release fertilizers are especially used in valued crops such as vegetables, grains and cereals. These fertilizers are also used in nurseries and orchards. The use of specialty chemicals in limited-row crops is increasing primarily because of concerns about the environment, along with higher prices of grains, among other regulations.

Currently, the U.S. remains the biggest market for controlled-release fertilizers. In 2021, it made up about 82% of the market, recording a 70.4% growth during the study period. As precision farming and the industry at large continue to advance, the U.S. Department of Agriculture and the Environmental Protection Agency has partnered with different stakeholders to increase awareness about controlled-release fertilizers among farmers.

These stakeholders include the Nature Conservancy, IFDC, NCGA and the Fertilizer Institute. This is expected to increase production of field crops in the country. Some companies mentioned in the report include Nutrien Limited, Agro Liquid, ICL Specialty Fertilizers, Florikan, Compo Expert GMbh and Haifa Group Limited, among others.

The switch to precision farming may not be feasible for everyone engaged in farming, and that means that manufacturers of conventional fertilizers such as Compass Minerals International Inc. (NYSE: CMP) will still have a large customer base that will be needing fertilizers.

Compass Minerals International Inc. (CMP), closed Monday's trading session at $21.07, up 0.861656%, on 516,290 volume. The average volume for the last 3 months is 23.781M and the stock's 52-week low/high is $18.88/$39.78.

Microsoft Corp. (MSFT)

The Street, InvestorPlace, Kiplinger Today, The Online Investor, Zacks, Daily Trade Alert, StockMarketWatch, Schaeffer's, StreetInsider, StreetAuthority Daily, Money Morning, MarketClub Analysis, Investopedia, TopStockAnalysts, Trades Of The Day, IT News Daily, InvestorGuide, Market Intelligence Center Alert, internetnews, MarketBeat, PROFIT CONFIDENTIAL, Early Bird, The Motley Fool, Uncommon Wisdom, Daily Wealth, internet, Top Pros' Top Picks, Wealth Insider Alert, Daily Market Beat, Flagler Financial Group, Investor Guide, ProfitableTrading, Street Insider, The Wealth Report, Louis Navellier, Barchart, Cabot Wealth, The Street Report, INO Market Report, CNBC Breaking News, Wyatt Investment Research, StocksEarning, SmarTrend Newsletters, Dividend Opportunities, SiliconValley, Daily Profit, MarketWatch, StrategicTechInvestor, Insider Wealth Alert, Money and Markets, GorillaTrades, Investors Alley, CustomerService, iStockAnalyst, TradingAuthority Daily, INO.com Market Report, The Growth Stock Wire, Trading Markets, TheStockAdvisors, Wealth Daily, Investment U, FreeRealTime, WStreet Market Commentary, Marketbeat.com, Total Wealth, Investing Daily, Willy Wizard, Greenbackers, TipRanks, Energy and Capital, Wall Street Daily, Stansberry Research, TheStockAdvisor, Eagle Financial Publications, Daily Markets, AllPennyStocks, Market Intelligence Center, Trade of the Week, Investiv, Penny Stock Buzz, SmallCap Network, Dynamic Wealth Report, Money Wealth Matters, Shah's Insights & Indictments, Darwin Investing Network, Trader Prep, Contrarian Outlook, Market Authority, FeedBlitz, Forbes, DividendStocks, FNNO Newsletters, Power Profit Trades, The Night Owl, Wall Street Elite, SmallCapVoice, StockEarnings, Investor Update, Daily Dividends, TraderPower, BullDogReporter, Stockhouse, TradingMarkets, Short Term Wealth, QualityStocks, Jon Markman’s Pivotal Point, Stock Up Featured, Coattail Investor, Inside Investing Daily, Trading Concepts, StockTwits, InvestorsObserver Team, The Best Newsletters, InvestmentHouse, Investment House, The Trading Report, Investing Futures, Bourbon and Bayonets, PennyOmega, Wall Street Greek, CRWEFinance, Options Elite, Investing Lab, Momentum Traders, Traders For Cash Flow, Super Stock Investor, DrStockPick, TheOptionSpecialist, 24/7 Trader, The Weekly Options Trader, MarketArmor.com, ChartAdvisor, Stocks To Watch, YOLOTraderAlerts, The Stock Dork, SmallCapNetwork, CRWEWallStreet, PennyToBuck, Momentum Trades, Visual Capitalist, Stock Gumshoe, Agora Financial, Smartmoneytrading, Weekly Wizards, Lebed.biz, Leeb's Market Forecast, wyatt research newsletter, Early Investing, Wealthpire Inc., Market Pulse, The Tycoon Report, InvestorIntel, Todd Horwitz, StreetAlerts, BestOtc, Bullish Bankers, Google Alerts and Investing Signal reported earlier on Microsoft Corp. (MSFT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Recent advancements in the artificial intelligence (AI) field have significantly increased the scope of how the technology can be applied. With generative AI tools such as ChatGPT already helping users generate significant amounts of data every day, the technology has the potential to completely revolutionize many industries.

Experts in several fields could use AI to optimize their workflows and analyze mountains of data to reach new and potentially groundbreaking conclusions. However, the U.S. Patent and Trademark Office (USPTO) has ruled that artificial intelligence itself cannot be classified as an inventor. The USPTO has issued guidance on inventorship and patentability in the wake of the ongoing AI revolution for inventions that are developed with the assistance of AI.

According to the recently issued guidance, inventions made with the assistance of AI are patent eligible if at least one human contributor made a major contribution to their conception. This means that while AI cannot be a sole inventor, it may be used in the creation of patent-eligible inventions.

Conception refers to the process of constructing an invention, testing it and validating its workability. An invention can only be patented if a human contributed to this part of the invention process significantly. Additionally, the USPTO outlined several principal guidelines that can be used to help determine when and whether a human should get classified as an inventor when they use AI tools for assistance.

The federal agency also offered two examples to help guide inventors, practitioners and examiners in determining whether their AI-assisted inventions are eligible for patents.

This announcement comes two years after the Federal Circuit Court ruled that only a human inventor could be named as the valid inventor of an invention, not an AI system. The ruling established that U.S. law does not provide protections for AI-made inventions. However, the court noted that its ruling did not account for the more complex issue of inventions that were developed with the assistance of artificial intelligence.

Shortly after the ruling, President Joe Biden’s administration passed an ai executive order directing the USPTO director to offer an opinion on the issue of inventions made with the assistance of AI. As per the executive order, the USPTO director is tasked with guiding USPTO parent applicants and examiners on the use of AI in inventorship. The USPTO issued this guidance in mid-February and has now opened a 90-day comment period for the public to comment.

Enterprises that are on the cutting-edge of developing AI solutions, such as Microsoft Corp. (NASDAQ: MSFT), are likely to have valuable input to share with the USPTO regarding the role that AI can play in coming up with inventions, and how such inventions can be legally protected.

Microsoft Corp. (MSFT), closed Monday's trading session at $404.52, off by 0.418492%, on 16,120,752 volume. The average volume for the last 3 months is 10.422M and the stock's 52-week low/high is $245.73/$420.82.

QuantumScape Corp. (QS)

InvestorPlace, Schaeffer's, StockEarnings, StocksEarning, MarketClub Analysis, QualityStocks, The Street, MarketBeat, The Online Investor, GreenCarStocks, Cabot Wealth, Daily Trade Alert, Top Pros' Top Picks, FreeRealTime, BUYINS.NET, CNBC Breaking News, Green Energy Stocks, wyatt research newsletter, Atomic Trades, Trades Of The Day, Zacks, TipRanks and INO Market Report reported earlier on QuantumScape Corp. (QS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dodge has unveiled electrified versions of the iconic Charger muscle car. The Stellantis brand will offer two battery-powered iterations of the Dodge Charger that provide drivers with the power of a massive V8 engine without the associated pollution. Given the Charger’s place in America’s muscle-car culture, the launch of electrified versions is a sign that the space is increasingly adapting to electric cars.

Battery electric vehicles (BEVs) are a feasible solution to the transport industry’s massive greenhouse-gas emission dilemma. Transportation is responsible for nearly a third of greenhouse-gas emissions in the United States, because the overwhelming majority of road, water and air vehicles use fossil fuels. While effectively replacing ships and airplanes with electric versions will undoubtedly be challenging (or maybe even impossible with current technology), electric vehicles are already a viable and available transportation option. Replacing an internal combustion engine with a rechargeable battery pack and electric motor eliminates emissions at the tailpipe, making BEVs a great means of cutting tailpipe emissions across the entire transportation space.

Like most major vehicle manufacturers and brands, Dodge parent company Stellantis is also adopting electric-vehicle technology. Production of the electric Dodge Charger will occur at the Stellantis factory in Windsor, Ontario, with the facility switching between producing EVs and conventional petrol- and diesel-powered vehicles based on consumer demand.

The two- and four-door electric Dodges are called Charger Daytona after the Florida-based Nascar runway and will feature two different powertrains. The larger powertrain can deliver up to 670 horsepower and has an acceleration of 0 to 60 miles in only 3.3 seconds, while the second has 496 horsepower and an acceleration of 0 to 60 miles in 4.7 seconds. Both versions will feature Dodge’s Fratzonic Chambered Exhaust to produce the V8’s telltale roar. According to Dodge, the high-performance electric Charger will be the fastest and most powerful muscle car on the globe at launch.

Dodge will continue producing the gas-powered Charger alongside the electric iterations as it already holds a decent market share in the muscle-car segment. However, these versions won’t feature the massive Hemi V8 engine. When Stellantis first announced that it would halt production of the fossil fuel-powered Challengers and Chargers last year, it seemed like the thundering muscle cars were at the beginning of their final decline.

However, Dodge CEO Tim Kuniskis hinted at gas-powered versions of the muscle cars that would endure the brand’s decision to electrify its lineup. Kuniskis noted signs of the gas version of the popular automobile living on were always there and that the plan was always to retain some old-school versions of the muscle cars.

For companies that operate entirely in the EV space, such as QuantumScape Corp. (NYSE: QS), the focus is on developing models that will lure customers away from legacy automakers and create brand loyalty.

QuantumScape Corp. (QS), closed Monday's trading session at $6.04, even for the day, on 4,274,125 volume. The average volume for the last 3 months is 36,650 and the stock's 52-week low/high is $4.99/$13.86.

The QualityStocks Company Corner

Bravo Multinational Inc. (OTC: BRVO)

The QualityStocks Daily Newsletter would like to spotlightFathom Bravo Multinational Inc. (OTC: BRVO).

Video streaming revenue worldwide is expected to reach $137.70 billion by 2027 due to the growing user base adopting video streaming platforms

Bravo recently entered an Asset Purchase Agreement to acquire assets of Streaming TVEE, Inc., with plans to launch TVee NOW(TM) during Q1 2024

TVee NOW(TM) will offer traditional broadcast television, encompassing cable and satellite networks, through a joint venture with a third party, which is set to close at a later date

TVee NOW(TM) will be available for download in the Roku Channel Store, Apple Store, and Google Play Store

Video streaming revenue worldwide has exploded over the last decade, with an estimated value of $108.50 billion in 2024. By 2027, the market is expected to reach $137.70 billion, growing at a CAGR of 8.27% from 2024 to 2027 (https://ibn.fm/X8qMy). This growth is supported by a fast-growing user base, thanks to the worldwide adoption of video streaming platforms. Bravo Multinational (OTC: BRVO), a company actively exploring opportunities in the entertainment, hospitality, and technology sectors, is exploring streaming to generate long-term value for its shareholders through high-growth business ventures.

Bravo Multinational Inc. (OTC: BRVO) actively explores opportunities in the entertainment, hospitality and technology sectors to generate long-term value for its shareholders through high-growth business ventures. Currently focused on pioneering innovative solutions in the digital content landscape, the company’s goal is to provide cutting-edge and diverse content experiences to a global audience.

In February 2024, Bravo finalized a deal to acquire Streaming TVEE Inc.’s assets, marking a pivotal step in establishing its flagship offering, aptly named TVee NOW™. The acquired assets provide the company with the technology and foundation to soon offer streaming services including Video-On-Demand (VOD) and linear TV, often referred to as traditional broadcast TV, which encompasses cable and satellite networks, through a joint venture with Pythia Experiences.

TVee NOW™ plans to offer a wide range of on-demand content, including movies, series, concerts and original programming, at minimal or no cost to viewers. The service, set for beta launch in Q1 2024, will be accessible across various devices, with dedicated apps available on platforms such as Roku, Apple and Google Play stores, reinforcing Bravo’s commitment to innovation and audience accessibility.

The company is based in Virginia Beach, Virginia, with a second office soon opening in Las Vegas, Nevada.

Products

TVee NOW’s streaming service will offer a portion of its content for free, catering to the growing demographic of cord-cutters and aligning with the dynamic landscape of advertising-based video on demand (AVOD) streaming. Bravo’s Over-The-Top (OTT) streaming platform is specifically crafted to deliver content directly to viewers via the internet, accessible through a browser or freely downloadable apps on smartphones, tablets and smart TVs.

Bravo’s planned strategic approach for content is to first integrate partnered Free Ad-Supported TV (FAST) channels, programmatic advertising and a tiered revenue sharing model. Additionally, the company plans to complete the deal with Pythia Experiences, enabling a hybrid model comprised of AVOD, utilizing programmatic advertising through ad servers, and Subscription-based Video-on-Demand (SVOD), which the company plans to offer at competitive rates compared to other services. With this model completed, Bravo can bridge the gap until the company can ultimately create its own original content.

Through the asset purchase agreement with Streaming TVEE, Inc., the company obtained exclusive rights, image and likeness, label waivers and exploitation rights for streaming of 117 high-definition music and comedy performances, each offering a director’s cut and multiple camera perspectives. Some of the music artists include Snoop Dogg, H.E.R., Kings of Leon, Alicia Keys and Bone Thugs-N-Harmony, along with comedic performances from Bill Burr, Jim Gaffigan, Kristen Schaal, Rob Delaney and others. This original footage will allow Bravo to recreate shows in diverse formats, which can showcase these concert films in a compelling full-feature format.

Market Opportunity

A report from Fortune Business Insights, a global market research and reporting firm, estimated the global video streaming market at $455.45 billion in 2022. It is projected to grow from $554.33 billion in 2023 to $1.9 trillion by 2030, achieving a CAGR of 19.3% during the forecast period.

Growth drivers, according to the report, include a rising number of users of Video-on-Demand services (YouTube, for example) worldwide and the growing adoption of OTT content providers (like Netflix and Hulu, among many others) by consumers, as well as consumers’ willingness to spend more for streaming video content.

Management Team

Grant Cramer is CEO and Director of Bravo. He has more than 30 years of experience as an actor, writer, director, producer and production executive. As founder and president of Landafar Entertainment and Global Pictures Media, he has overseen development and production of 14 feature films. He executive produced Lone Survivor, November Man and Arctic Dogs. He produced And So It Goes, directed by Rob Reiner and starring Michael Douglas and Diane Keaton. His short film Say Goodnight, Michael won several awards, including the Grand Jury Award at the New York International Independent Film Festival.

Frank Hagan is Bravo’s President and Director. He is an Emmy-nominated producer with over 30 years of experience in the entertainment industry. He is the former Programming Director and GM of QTN. He has produced shows for major networks and companies, including Discovery Channel, History Channel and Relativity Media. Most recently, he served as a consulting producer for Electric Entertainment’s ElectricNOW! and the Saturn Awards and worked as a regular weekly panelist for Outlaw Internet Radio.

Richard Kaiser is CFO and Director of Bravo. He is also CFO at BioForce Nanosciences Holdings Inc. and Gold Rock Holdings Inc. He serves on the board of Element Global Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings Inc. He previously directed investor relations for Royal Standard Minerals Inc. and Scorpio Mining Inc. He was also Head of Corporate Communication and Investor Relations at Air Packaging Technologies Inc. and Puff Pack Industries Inc.

Kayla Slick is COO and Director at Bravo. She has more than 15 years of experience in various industries, including finance, healthcare, technology, retail, hospitality and entertainment. She co-founded The PRIME Symposium and significantly increased revenues for INSIDE Public Accounting. She held positions at Interactive Digital Solutions, where she founded the Sales Development Program and was later promoted to Marketing Communications Director for IDS’ flagship virtual patient observation product.

Bravo Multinational Inc. (OTC: BRVO), closed Monday's trading session at $0.22, up 15.7895%, on 85,164 volume. The average volume for the last 3 months is 137,365 and the stock's 52-week low/high is $0.0461/$0.95.

Recent News

Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF)

The QualityStocks Daily Newsletter would like to spotlight Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) .

Environment, social and governance ("ESG") projects are becoming increasingly popular among investors, corporations and governments globally. With the effects of human-induced climate change becoming clearer by the day, there is a growing need for increased accountability in ESG reporting among corporations and governments because they are typically responsible for the majority of the world's emissions. Trillions of dollars are being earmarked for such ESG projects, and PriceWaterhouseCoopers forecasts that investment in ESG projects will almost double from $18.4 trillion in 2021 to nearly $34 trillion in 2026. ESG holdings are also on track to account for 21.5% of all the world's managed assets in only two years, thanks to increased corporate, government and investor adoption of environment, social and governance projects. Creating a return gap between green and brown companies could increase the ROI for investors who buy green assets. This would require flexible demand for capital, which would in turn shift investment from brown companies to green ones without causing a drastic effect on the return gap. It would be interesting to hear how companies that have, on their own volition, embraced ESG principles, such as Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), are faring in terms of seeing ROI on their investment.

Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) is a public oil and gas exploration, exploitation and development company focusing on conventional oil and gas reservoirs in Western Canada. The company uses its experience to develop, acquire and drill assets with potential for primary and secondary recovery.

Prospera is primarily focused on optimizing hydrocarbon recovery from legacy fields through environmentally safe and efficient reservoir development methods and production practices. It is in the midst of a three-stage restructuring process aimed at prioritizing cost effective operations while appreciating production capacity and reducing liabilities.

The company is based in Calgary, Alberta, Canada.

Operations

Prospera’s core properties include more than 42,000 cumulative acres across Cuthbert, Luseland and Heart Hills in Saskatchewan and Red Earth and Pouce Coupe in Alberta. In total, the company estimates that there are half a billion barrels of oil in place at these sites accounting for 20+ years of forward project lifespan, with as little as 8% of total reserves having been recovered via legacy vertical well technology.

Restructuring Initiative

In 2021, Prospera enacted a top-down reorganization. The early results of these efforts were on display in May 2023, when the company reported a three-fold year-over-year increase in annual revenue for 2022 alongside drastically reduced operating costs and record-high cash flow from operations.

Prospera noted in the news release that it has positioned itself in 2023 to execute the second phase of its development plan aimed at increasing production through medium-oil development in Alberta and leveraging horizontal wells to capture the significant remaining reserves in Saskatchewan.

During the company’s investor summit in August 2023, Prospera CEO Samuel David provided more information regarding this three-phase strategy:

Phase I

Prospera completed the first phase of its restructuring by optimizing operations at its existing assets and addressing legacy arrears and non-compliance issues.

At the beginning of this transformation, the company was producing just 80 barrels of oil equivalent (BOE) per day. In Q4 of last year, Prospera peaked at nearly 1,200 BOE per day. Its breakeven is around 500 barrels per day, illustrating the opportunity for free cash flow. This prospect has driven Prospera’s capital development and optimization in recent quarters.

After a temporary slowdown in production due to harsh winter conditions, Prospera is currently producing about 800 BOE per day and anticipates an additional 300-500 barrels of daily production following the completion of ongoing site maintenance work.

This sustained increase has pushed the company’s NPV from roughly $3 million prior to the restructuring efforts to approximately $72 million today.

In an effort to build on this progress and maximize its available resources, Prospera piloted two horizontal reentries to assess a potential horizontal well transformation at its properties.

Phase II

Following up on the optimization efforts of Phase I, Prospera aims to commence a horizontal well transformation at its properties in the coming months. Based on its pilot wells from Phase I, the company has proposed 10 horizontal well locations at its Cuthbert and Heart Hills properties.

Prospera has likewise proposed eight medium light oil direction wells at its Alberta property, and it is exploring strategic acquisitions aimed at expanding its core area and diversifying its product mix.

Other facets of Phase II include piloting an enhanced oil recovery (EOR) application and continuing to execute its liability management goals and ESG initiatives. Prospera has already abandoned 60 vertical wells as part of its three-year LMR plan to reclaim surface land and reduce the environmental footprint of its operations.

Phase III

Beginning next year, Phase III of Prospera’s corporate redevelopment strategy will focus on continuing the company’s horizontal modular development to appreciate production and optimize recovery of remaining reserves. Prospera intends to implement full-scale EOR applications based on the results of its Phase II pilot program, which is forecast to optimize recovery by greater than 10%.

Prospera also intends to continue its acquisition strategy to diversify its product mix. Its goal, as detailed by in August 2023 investor summit, is to attain 50% light oil, 40% heavy oil and 10% gas – all while continuing to eliminate carbon emissions as part of its existing ESG initiatives.

Poised for Growth

Following its transformational efforts in 2022, Prospera is poised to achieve record growth in 2023. The company has forecast significant reductions in production costs through 2024, alongside sizable increases in daily production.

Prospera is currently exploring strategic acquisition targets to potentially increase its production beyond 5,000 BPD while expanding its reserve base to a billion barrels.

Market Opportunity

While the oil and gas industry faces long-term geopolitical and macroeconomic uncertainty, there is a clear trend to secure supply in the short term. According to Deloitte, the global upstream industry ended 2022 with some of the highest free cash flows on record, driving reinvestment in hydrocarbons and overall investment in clean energy.

The Energy Information Administration recently forecast a dip in global oil inventories over each of the next five quarters, placing upward pressure on oil prices. The agency further forecasts a YoY increase in fuel consumption, exacerbating the effects of OPEC+ production cuts that are set to remain in place through 2024.

For Prospera, these forecasts are promising. The company aims to build on its recent financial growth in the coming months (Prospera reported a three-fold YoY increase in revenue to $13.9 million in 2022), hitting a projected $57 million in total revenue by the end of 2024 while working to expand its core area holdings through accretive M&A transactions.

Leadership Team

Prospera is led by a team with extensive, diverse petroleum industry experience spanning both reservoir management and operations of oil and gas assets. The team boasts a proven track record of reorganizing companies, structuring financing arrangements and positioning for growth.

Samuel David is the company’s President and CEO. He brings to Prospera over 32 years of experience in operation, development and management of oil and gas assets and companies. Mr. David holds a B.Sc. in Mechanical Engineering and a B.A. in Economics from the University of Calgary. His background consists of both engineering and executive management experience with majors Petro-Canada, AEC Oil & Gas (now EnCana / Cenovus) and Husky Energy, as well as founding and operating juniors Ventura Energy and First West Petroleum. Mr. David has proven expertise in corporate planning, production, reservoir engineering, depletion strategies, EOR, property evaluations, acquisitions and divestitures.

George Magarian is VP Subsurface for Prospera. He is a professional petroleum geologist (APEGA) with over 36 years’ experience in the Western Canada Sedimentary Basin. After graduating with an Honors B.Sc. degree in Earth Science from the University of Waterloo, Mr. Magarian spearheaded many successful exploration programs, conducted evaluations for improved recovery schemes and assessed/exploited unconventional oil reservoir opportunities. He has held roles of increasing responsibility, from exploration geologist at oil industry major Petro-Canada and intermediates Anderson Exploration and Jordan Petroleum, to geoscience manager and VP exploration at junior companies Ionic Energy, Gentry Resources and Westfire Energy.

Chris Ludtke is the company’s VP Finance & Accounting. He is a high functioning finance leader with extensive expertise in finance, budgets and planning, accounting, economic evaluation, management, governance and sound decision making. Mr. Ludtke has 20 years of experience within the oil and gas, clean energy and renewables industries, including 12+ years working for Husky Energy before moving into an executive role in the junior oil and gas and hydrogen space. He graduated from the University of Lethbridge (Bachelor of Management) and is a Chartered Professional Accountant in the Province of Alberta.

Matthew Kenna is the CFO of Prospera. He has over 30 years’ experience leading organizations and helping them expand, drive efficiencies and grow profitability. Mr. Kenna is a professional accountant (CPA, CMA) and spent 15 years heading up the financial and operating departments at KUDU Industries, where he fostered financing arrangements, client relationships and manufacturing teams to take the organization from $35M to $150M in revenue. He has extensive experience turning companies around, growing them and building efficient organizations.

Prospera Energy Inc. (OTC: GXRFF), closed Monday's trading session at $0.0675, up 4.3277%, on 48,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.95/$.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

Astiva Health is revolutionizing patient involvement in healthcare, particularly for the aging population

Beyond offering healthcare services, Astiva is dedicated to creating a supportive health community

With patients at the center, Astiva Health is transforming aging healthcare into a proactive, participatory experience

The United States is in the midst of a global demographic shift toward an aging population, with the U.S. Census Bureau projecting that by 2034, adults aged 65 and older will outnumber children under the age of 18 for the first time in U.S. history (https://ibn.fm/yGoyH). With this shift, the demand for a more holistic approach to healthcare has never been more critical. Astiva Health stands at the forefront of this transformation, championing a model of care that emphasizes proactive health management and a healthy lifestyle over traditional reactive methods.

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News

chart

Diamond Lake Minerals Inc. (OTC: DLMI)

The QualityStocks Daily Newsletter would like to spotlight Diamond Lake Minerals Inc. (OTC: DLMI).

Avrio Worldwide has acquired the HUMBL Financial brand, products, and services

Avrio will issue HUMBL Financial branded products and services, including the BLOCK ETXs and BLOCK Indexes, into consumer markets through digital wallets and web trading platforms

HUMBL will acquire the equivalent of $5 million in Avrio shares – a 10% stake in the company, as well as revenue shares of 2.5%, and a seat in the company for HUMBL's CEO

Diamond Lake Minerals (OTC: DLMI), a multistrategy operating company offering traditional investors an entry point to the future of digital securities, was featured in a recent Proactive release. A tech-enabled platform, Proactive works to empower companies globally with a comprehensive investor engagement solution across their business lifecycle. During the interview, which was held on International Women's Day, Diamond Lake Minerals CEO Brian J. Esposito and advisory board member Agnes Budzyn talked with Proactive host Steve Darling about the company's commitment to equity and innovation. Esposito specifically pointed to Budzyn's leadership in the security token and digital asset space and talked about how valuable her expertise and insight has been in guiding the company's strategic vision. He also discussed the "democratizing potential of technologies" such as security tokens, noting the increased opportunities for wealth creation regardless of gender. A seasoned professional with a rich background in blockchain investing and Wall Street, Budzyn talked about the company's role in shaping the future of digitalization, emphasizing the significance of adaptability and experimentation in navigating industry trends. Proactive works with innovative growth companies quoted on the world's major stock exchanges, helping executives to engage intelligently with investors.

To hear the full broadcast, visit https://ibn.fm/a2imC

To view the full press release, visit https://ibn.fm/3YQoU

Diamond Lake Minerals Inc. (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its established M&A roadmap, is to responsibly innovate and develop promising businesses that are likely to benefit from the ongoing shift toward digital assets. Through this approach, Diamond Lake Minerals provides traditional investors an opportunity to gain exposure to the emergence of regulated digital securities through a more familiar investment vehicle – the purchase of stock.

Founded in 1954 and headquartered in Salt Lake City, Diamond Lake Minerals is positioning itself as a leader in the digital asset and security token space. The company’s mission is to bring back to the public markets timeless business principles focused on healthy, sustainable growth and strong earnings with a goal of creating value for stakeholders in the modern digital world.

Diamond Lake Minerals believes the future of financial markets is set to be revolutionized by tokenization. Tokenization refers to the use of digital assets that can be traded via protocols with instantaneous settlement and reduced fees, eliminating the need for traditional clearing or settlement processes. Beyond efficiency, the emerging landscape emphasizes transparency, liquidity and security in asset management and investment.

With the backing of Esposito Intellectual Enterprises and its 20+ years of experience, Diamond Lake Minerals has access to the expertise of 110+ companies and 200+ joint ventures, along with knowledge spanning 25+ industries. The company is creating a vertically integrated ecosystem that encompasses various high-growth sectors. This integration aims to maximize operational efficiencies and profitability across all business units.

Products & Services Portfolio

Diamond Lake Minerals, guided by its strategic partnerships and future roadmap, envisions a diverse portfolio across multiple industries, as shown in the overview below. The company is poised to redefine the conglomerate model for the 21st century, with a focus on vertical integration, digital securities and sustainable growth.

Its target market segments include:

  • Fashion: DLMI seeks stakes in brands blending timeless aesthetics with tech influences.
  • Beauty: DLMI eyes partnerships with innovators elevating beauty through sustainable practices.
  • Real Estate: DLMI aims for interests in ventures modernizing property transactions via blockchain.
  • Hospitality: DLMI’s vision includes associations with enterprises enhancing guest experiences via tech integration.
  • Liquor: DLMI aspires to collaborate with unique distillers merging tradition and innovation.
  • IoT: DLMI intends to invest in solutions seamlessly connecting the digital and physical worlds.
  • Wireless: DLMI envisions stakes in wireless tech optimizing global communication.
  • Technology: DLMI plans to back pioneers driving the next tech revolution.
  • Maritime: DLMI seeks partnerships in maritime solutions emphasizing green initiatives.
  • Aviation: DLMI’s strategy includes holdings in aviation innovators focusing on efficiency.
  • Aerospace: DLMI aims to support ventures pushing boundaries in space exploration.
  • Education: DLMI collaborates with platforms revolutionizing learning through tech.
  • Charity: DLMI eyes alliances with charitable entities leveraging transparency via blockchain.
  • Healthcare: DLMI foresees investments in healthcare tech personalizing patient care.
  • TV: DLMI intends stakes in TV platforms innovating content delivery.
  • Film: DLMI aspires to support filmmakers merging storytelling with immersive tech.
  • Music: DLMI plans interests in music ventures amplifying artists through digital platforms.
  • Entertainment: DLMI targets stakes in platforms redefining entertainment paradigms.
  • IP: DLMI envisions collaborations safeguarding intellectual properties via tech solutions.
  • Data Management: DLMI seeks ventures optimizing data utilization and insights.
  • Data Storage: DLMI’s roadmap includes alliances with secure data storage solutions.
  • Streaming: DLMI intends to back streaming platforms prioritizing user experience.
  • Real World Assets: DLMI eyes investments translating tangible assets into digital value.
  • Gold & Silver: DLMI aims for stakes in platforms digitizing precious metal trading.
  • Sports: DLMI envisions collaborations enhancing sports experiences via tech integration.
  • Sports Technology: DLMI seeks ventures revolutionizing athlete performance and fan engagement.
  • Water: DLMI plans to back solutions ensuring water sustainability and accessibility.
  • Water Treatment: DLMI targets investments in eco-friendly water purification technologies.
  • Animation: DLMI eyes stakes in animation houses blending art with cutting-edge tech.
  • Studio Production: DLMI’s vision includes support for studios transforming content creation.
  • Consumer Products: DLMI seeks partnerships with brands prioritizing consumer-centric innovations.
  • Collectables: DLMI envisions collaborations with platforms digitizing unique collectibles.
  • Digital Assets: DLMI aims to invest in ventures maximizing the potential of digital ownership.
  • Web3: DLMI aspires to back pioneers ushering in the decentralized web era.
  • Identity Management: DLMI eyes solutions prioritizing user identity security in the digital space.
  • Media & Journalists: DLMI seeks alliances promoting unbiased reporting and content democratization.
  • Metaverse: DLMI envisions stakes in ventures crafting immersive virtual universes.
  • Space Economy: DLMI targets investments in ventures monetizing space exploration.
  • Modular Homes: DLMI plans interests in solutions revolutionizing home construction.
  • Financial Technology: DLMI seeks partnerships modernizing financial transactions.
  • Gaming: DLMI aims to back game developers enhancing user immersion.
  • Travel: DLMI eyes collaborations transforming travel experiences through tech.
  • Health & Wellness: DLMI’s strategy includes investments in holistic health tech solutions.
  • Augmented Reality: DLMI envisions stakes in AR platforms blurring reality and digital.
  • AI: DLMI seeks to support AI innovations humanizing tech interactions.
  • Esports: DLMI targets investments in platforms amplifying esports experiences.
  • Construction: DLMI plans to back ventures modernizing construction practices.
  • Virtual Reality: DLMI intends stakes in VR platforms offering alternate realities.
  • Retail Tech: DLMI envisions collaborations digitizing retail experiences.
  • Biotechnology: DLMI seeks ventures pushing boundaries in biotech innovations.

Market Opportunity

According to Diamond Lake Minerals’ business plan executive summary, the market for digital securities is projected to grow from $10 billion in 2022 to $1 trillion by 2028, a CAGR of 45% for the forecast period.

The global blockchain market value is expected to grow from an estimated $3 billion in 2020 to $39.7 billion by 2025, marking a CAGR of 67.3% for the period. Valued at $2.28 billion in 2021, the Security Token Offerings market is projected to grow at a CAGR of 19%. This growth is expected to be driven by the rising adoption of tokenization and the increasing prominence of STOs, especially in North America.

In addition, the global investment management market is projected to grow from a value of $100 trillion in 2020 to $178 trillion by 2025, recording a CAGR of 7.2% over the period.

Management Team

Brian J. Esposito is CEO of Diamond Lake Minerals. As founder and CEO of Esposito Intellectual Enterprises LLC, he brings over 20 years of diverse experience in sectors like manufacturing, technology, music and real estate, and is known for his global executive networking and balance sheet optimization skills.

Michael Reynolds is President and Director of Diamond Lake Minerals. With 35 years in private finance and M&A, he has been instrumental in growing companies like Herbalife through reverse acquisition, as well as elevating JB Oxford to $120 million in revenue. His expertise in operational management and business development ensures professional solutions for clients’ business interests.

Jon Karas is DLMI’s senior transaction and investment executive. As the CEO and co-founder of Akon Legacy Ventures, he structured, negotiated and closed numerous transactions focused on innovation and social impact in smart cities, blockchain, agriculture, mining and technology. He co-founded and led multiple companies in media and entertainment and was the driving force behind the development, financing and production of a broad range of film and television content.

Advisory Board

Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital and Chairman of SALT, brings to Diamond Lake Minerals unparalleled expertise in finance, technology and business strategy. He is expected to be instrumental in shaping DLMI’s strategic direction as the company continues to redefine the future of traditional and digital securities.

Larry Namer, Founder of E! Entertainment TV and President of Metan Global, boasts a remarkable career spanning more than half a century. He is an esteemed veteran of the entertainment industry, renowned for his influential contributions to cable television, live events, music and new media. He also leads LJN Media, a consulting firm known for its cross-industry expertise in technology, business and finance.

Andrew Fromm is a seasoned CEO and consultant with a focus on music publishing. He is known for his expertise in asset sales, songwriting and artist development. His extensive network extends beyond the music industry, showcasing his versatility and authority in the field.

Brandon Fugal is the Chairman of Colliers International in Utah and a former EY Entrepreneur of the Year. He has co-founded multiple ventures, including Coldwell Banker Commercial Advisors, Cypher, Axcend and Texas Growth Fund, and he is a recognized authority in real estate and entrepreneurship.

Michael Malik Sr. is a Detroit-based entrepreneur with a $750 million net worth, known for his pivotal role in legalizing gambling and developing major casino projects across the U.S., including Detroit’s MotorCity Casino and various Native American gaming ventures. He brings to Diamond Lake Minerals a wealth of experience and a proven track record in the gaming, sporting and entertainment industries spanning over five decades.

Raul Leal is an experienced CEO in the hospitality sector, known for his visionary leadership at SH Hotels & Resorts and former role at Virgin Hotels, where he secured over $500 million in funding and revolutionized guest experiences.

Agnes Budzyn, an accomplished entrepreneur and CEO of Bluedge Ventures, brings to the company a rich history in traditional finance and blockchain technology, serving on various global boards and committees. She has been recognized by the World Economic Forum and numerous institutions for her expertise and contributions to bridging legacy finance with emerging digital asset infrastructure.

Diamond Lake Minerals Inc. (OTC: DLMI), closed Monday's trading session at $3.75, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.35/$5.90.

Recent News

Freight Technologies Inc. (NASDAQ: FRGT)

The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).

Fr8Tech recently participated in the Geotab Connect 2024 event as a marketplace partner, covering insights into connected vehicles, data intelligence, artificial intelligence, and sustainability

Last year, the company integrated its Fr8App freight-matching platform with Geotab's open API, boosting real-time visibility and efficiency for shippers and carriers

Fr8Tech recently secured a cross-border logistics services contract with Kawasaki Motores de Mexico, a division of manufacturing conglomerate Kawasaki Heavy Industries, Ltd.

Freight Technologies (NASDAQ: FRGT) ("Fr8Tech"), a technology company developing solutions to optimize and automate the supply chain process and freight logistics, recently participated in the prestigious Geotab Connect 2024 event as a distinguished marketplace partner. The Geotab Connect 2024 took place in Las Vegas February 14 to 16, 2024, delivering unparalleled insights into the ever-evolving landscape of connected vehicles, data intelligence, artificial intelligence, and sustainability (https://ibn.fm/jbgKE).

Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.

Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.

The Fr8Tech Solutions Suite

Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:

  • Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
  • Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
  • Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
  • Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
  • Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
  • Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

Commitment to the Environment

Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.

Fr8University

Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.

Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.

Market Outlook

Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.

Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.

Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.

Management Team

Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.

Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).

Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.

Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.

Freight Technologies Inc. (NASDAQ: FRGT), closed Monday's trading session at $1.62, off by 1.8182%, on 338,792 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.43/$34.10.

Recent News

SOHM Inc. (OTC: SHMN)

The QualityStocks Daily Newsletter would like to spotlight SOHM Inc. (OTC: SHMN).

Recently published data shows that rheumatoid arthritis patients have a heightened risk for developing depression. This study is the first to investigate the link between rheumatoid arthritis and the risk of developing depression. The researchers' objective was to examine the effect of anticyclic citrullinated peptide and rheumatoid factor antibodies on depression in patients with rheumatoid arthritis and find data on the effect of DMARD prescriptions on rheumatoid arthritis-associated depression. These antibodies serve as markers of illness severity and offer insights into the risk of comorbidity. In their report, the researchers stated that the presence of comorbid depression in rheumatoid arthritis patients had been linked to heightened disease activity, pain exacerbation, less frequent remission, poor health-related quality of life, heightened risk of myocardial infarction, greater utilization of health care services and higher rates of mortality. They also noted that preventing and/or managing depression could be an effective approach to improving the overall quality of life and health of these patients. They are now focused on better understanding the underlying mechanisms behind their findings. The researchers involved in the study include Keun Hye Jeon, Kyungdo Han, Hyungjin Kim, Yeonghee Eun, Chun Il Park, Jinhyoung Jung and Dong Wook Shin. Their findings were reported in the "JAMA Network Open." As more companies such as SOHM Inc. (OTC: SHMN) focus on developing and commercializing treatments for different forms of arthritis, the relief that patients experience from their pain could possibly contribute to reductions in the prevalence of depression within this patient population.

SOHM Inc. (OTC: SHMN) is a generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” (Global Prosperity). SOHM was founded in 1998 and is headquartered in Chino Hills, California.

The company’s primary goal is to create and produce cutting-edge generic medications that span a wide range of treatment areas, all while ensuring top-tier quality and keeping prices affordable. SOHM is dedicated to fully complying with all relevant regulatory prerequisites and upholding the most rigorous industry benchmarks, including the guidelines set forth by WHO-CGMP and USFDA.

Achievements and Milestones

SOHM is a recognized generic pharmaceutical manufacturer, with production and marketing of generic drugs covering all major treatment categories. SOHM also markets innovative formulations and packaging for various therapeutic segments, such as cosmeceuticals, nutraceuticals and OTC oral dosage formulations, with operations spanning India, the Philippines, Uganda, the U.S., the UK and the EU.

SOHM successfully launched a unique and innovative Salic-2 face wash, FōHM by SOHM, during the Oscar after party in Hollywood. The innovative Salic-2 offering in translucent gel form is marketed as an acne medication in the U.S. cosmeceutical market.

With proficiency in both manufacturing and marketing, SOHM stands out. The company holds licenses for producing over 300 products and has established distribution partnerships with firms in the United States, the Philippines and Uganda. Additionally, SOHM’s repertoire includes the launch of an innovative protein supplement, I-Prolec, featuring a distinct composition—a first-of-its-kind in India.

In 2012, SOHM gained recognition as “the most emerging company in the recent past” at the National Integrated Medical Association Conference. The company’s growth was underscored by its inclusion in the roster of ‘Fastest Growing Public Companies’ according to the Orange County Business Journal.

SOHM Today

SOHM brings all of its expertise and market knowledge toward a new vision. The company continues to develop, manufacture and market generic pharmaceutical drugs for various treatment categories. It offers its products in various dosage forms, including tablets and capsules, creams and topicals, ointments and liquids. The company also provides anti-arthritic/analgesics, dermatological drugs, gastrointestinal and respiratory drugs, biotechnology products, anesthetics, immunosuppressive agents and other various treatments. In addition, it offers a skincare line that includes dry dermatoses, mixed skin infection, acne vulgaris and seborrheic dermatitis products.

SOHM markets its products directly and through partner alliance agreements to drug wholesalers, mass merchandisers, chain drug stores and mail-order pharmacies primarily in the U.S. and has previously done business in the Far East, Africa and Southeast Asia. The company is working with its alliance partner in the African continent and Latin American countries.

SOHM has developed a comprehensive marketing strategy encompassing a diverse range of tactics to promote all products. SOHM uses the power of digital marketing channels, social media campaigns and targeted advertising to significantly enhance awareness and recognition of product offerings.

All distribution networks are strengthened through valuable partnerships. SOHM has gained access to the extensive U.S. market through a strategic alliance with different wholesalers catering to C-stores and retailers. The company has likewise partnered with a distribution firm that holds a remarkable network of more than 4,500 independent pharmacy accounts.

Additionally, a strong partnership with a prominent distribution network in New Jersey enables SOHM to facilitate nationwide distribution to big distribution houses, hospitals and retail chain stores which include but are not limited to Walmart, Publix, Sam’s and many more retail giants, thus extending the company’s market presence.

SOHM Long-Term

A report by Grand View Research estimated the global nutraceuticals market at $291.33 billion in 2022 and forecasts expansion at a compound annual growth rate (CAGR) of 9.4% from 2023 to 2030. The report states primary factors driving the market growth are preventive health care, increasing instances of lifestyle-related disorders, and rising consumer focus on health-promoting diets. Additionally, increasing consumer spending power in high-growth economies is projected to contribute to the growing demand for nutraceutical products.

Grand View valued the global NSAID market at $19.55 billion in 2021 and forecast it would expand to nearly $30 billion by 2030, marking a CAGR of 5.36% for the period. Projected growth is attributed to factors like the rising prevalence of chronic pain across the world, coupled with a growing global geriatric population. In addition, increasing demand for OTC NSAIDs and the rising adoption of NSAIDs in treating headaches, migraine, toothaches and menstrual pain is expected to boost market growth.

Fortune Business Insights estimated that the global cosmeceuticals market was worth $54.57 billion in 2022 and projects the market will grow to a value of $96.23 billion by 2029, marking a CAGR of 8.4% during the forecast period. The report credits the projected growth to the prevalence of skin disorders around the world and the inclination of dermatologists to prescribe or recommend these products as compared to other treatments.

SOHM envisions a future where it evolves into a prominent global corporation, expanding its reach across international borders while upholding its fundamental core values. The company aspires to extend its export portfolio to encompass 11 countries, showcasing a robust international presence.

Aiming for financial stability, SOHM is committed to maintaining sufficient working capital to support its growth endeavors. The company’s forward trajectory involves strategic collaborations, mergers with diverse brands and a focused approach to business expansion through vertical integration and a balanced mix of organic and inorganic strategies.

In this pursuit, SOHM is dedicated to establishing its proprietary network of partners within the over the counter (OTC) sector. Furthermore, the company seeks heightened recognition within crucial therapeutic domains, including oncology, HIV, cardiovascular health, diabetes care and skincare-dermatology, solidifying its prominent standing in these pivotal segments.

Management Team

Baron Night is CEO, President, and Director at SOHM Inc. He has over 40 years of experience in various industries with extensive contacts in emerging markets. His leadership and track record are great assets to the company as SOHM continues to strengthen its position and develop large-scale distribution of generic drug lines.

David Aguliar, Ph.D., is the COO of SOHM. He has 22 years of experience in the pharmaceutical industry, including multiple research positions and scientific publications. He has an extensive background in pharmaceutical Chemistry Manufacturing and Controls (CMC), as well as quality assurance experience in preclinical and Investigational New Drug (IND) application filings of allogeneic cell-based therapies. He has a deep understanding of regulatory and clinical pathways, coupled with an extensive scientific and technical background in the fields of pharmaceuticals, biopharmaceuticals and gene editing tools research.

Dr. Krishna Bhat, MD PHD, FACC, has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from the American Heart Association, which was awarded in recognition of his commitment to excellence in the field of Cardiovascular Care through his leadership as an outstanding physician, researcher, and educator. He is also a recipient of the Miles Canada Fellowship Award and the J. Louis Levesque Fellowship Award from Montreal Heart Institute in Montreal, Canada.

Dewey Rushing is a Senior Compliance Remediation and Quality Professional with over 30 years of experience in Quality Assurance and cGMP Compliance for products regulated by the U.S. Food and Drug Administration (FDA). He served as a trained Consumer Safety Investigator at the FDA and Instructor at the Los Angeles District. He has in-depth knowledge in technology transfer of biologics and pharmaceutical products, as well as validation of manufacturing equipment, facility cleaning and critical utility systems maintenance. He has an extensive background in auditing GMP facilities, implementing quality systems and performing gap assessments of manufacturing processes and facilities. He has also directed remediation projects in response to federal compliance audit observations.

Sowmya Jacob, MBA-PGP, possesses over a decade of accomplished and evolving expertise in human resources management, along with manufacturing and operations management. She earned an MBA, complemented by advanced marketing certifications. Demonstrating a track record of achievement, she excels in cultivating collaborative work environments and orchestrating transformative changes that lead to heightened productivity. With adeptness in business analysis, she has occupied senior managerial roles, showcasing her mastery. An engaged participant in professional circles, she maintains active memberships in SPHR and CHRP.

SOHM Inc. (OTC: SHMN), closed Monday's trading session at $0.0013, off by 13.3333%, on 2,333,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0005/$0.0022.

Recent News

Turbo Energy S.A. (NASDAQ: TURB)

The QualityStocks Daily Newsletter would like to spotlight Turbo Energy S.A. (NASDAQ: TURB).

Turbo Energy S.A. (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally.

Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic installation. The Sunbox is powered by AI and features a software system that monitors the generation, use and management of photovoltaic energy by analyzing large amounts of data related to energy generation, consumption, market prices and weather forecasts. This AI system optimizes battery usage, reducing electricity bills and providing peak-use reduction and uninterruptible power supply functions.

Turbo Energy currently sells its photovoltaic energy equipment primarily through distributors for residential consumers in Spain, but it possesses the expertise and international perspective to expand its product portfolio into industrial and commercial scale and markets, as well as advancing the internationalization process it has already started. The company plans to expand into the industrial photovoltaic sector with its new Sunbox, launched in 2023, in higher power and capacity variants. Its goal is to become a significant player in this sector and contribute to the growth of renewable energy solutions.

The company was incorporated in 2013 and is based in Valencia, Spain. It operates as a subsidiary of Umbrella Solar Investment S.A.

Products

Lithium-Ion Batteries

Turbo Energy is one of the leading companies that introduced lithium-ion batteries for photovoltaic energy storage in Spain. Primarily for the home energy storage market, the company’s batteries have capacities from 2.24 kWh to 5.1 kWh in 24 and 48 volts. In addition, its 48V / 5.1 kWh units are available in a dual battery system.

Inverters

The inverter converts the direct current produced by the photovoltaic panels into alternating current that can be used by household appliances. It also regulates battery charging and discharging based on energy needs and optimizes utilization of generated renewable energy. Turbo Energy currently offers multiple models that cover most household installations.

All-in-One Sunbox

This product incorporates inverters, batteries and the rest of the components necessary to operate and protect the photovoltaic installation. This saves installation cost and assembly and configuration time while preventing errors. Notably, the latest Sunbox models also offer an EV charging option.

Software System

In communication with the inverter, the company’s software monitors energy flows between the photovoltaic panels, household consumption, storage and an optional electric vehicle charging station. The software allows users to customize an automatic backup mode based on weather forecasts, or manually select which part of the battery will be reserved for possible power outages. It also allows the battery to be used in a peak shaving mode, which leverages AI to trigger battery power when grid energy is most expensive, effectively reducing the amount of high-cost power drawn from the grid.

Market Opportunity

According to a report by Fortune Business Insights, a global research and reporting firm, the solar energy storage battery market was estimated to be worth $3.33 billion in 2022 and is projected to reach a value of more than $20 billion by 2030, marking a CAGR of 24.2% over the forecast period.

These batteries are crucial components of renewable energy systems, allowing for the storage of excess electricity generated by solar panels, so it can be used during times of no or low sunlight. By storing energy and supplying it when needed, these batteries reduce reliance on the power grid and maximize self-consumption while helping users avoid peak electricity rates. They also contribute to the transition toward a cleaner and more sustainable energy future by enabling residential consumers and businesses to use solar power even when the sun is not shining.

Management Team

Enrique Selva Bellvís is the CEO and founder of the Umbrella Group. In addition, he serves as vice-president of the Valencian Association of Energy Sector Companies industry group. Before his career in the solar energy sector, he was the founder and CEO of Innova Ingenieros Consultores. He holds a degree in industrial engineering with a specialization in energy from the Polytechnic University of Valencia and completed the Management Development Programme at the IESE Business School.

Mariano Soria is the Chief Innovation Officer for the Umbrella Group and serves as General Manager of Turbo Energy. He was CEO of Punt Moble XXI S.L. and continues to serve on that company’s board. Before that, he was the General Manager of REJMAR S.A., a land development company. He received his degree in industrial engineering and industrial organization from the Polytechnic University of Valencia, and his MBA from the European University of Madrid.

Alejandro Moragues is CFO of Turbo Energy. Previously, he held the position of Senior Corporate Auditor for U.S. company Euronet Worldwide Inc. and was an external auditor for PricewaterhouseCoopers. He holds a bachelor’s degree in business administration and management from the Polytechnic University of Valencia.

Manuel Cercos is Chief Commercial Officer at Turbo Energy. Previously, he held positions at Técnicas Aplicadas en Baterías S.L., where he served as Sales Director and Sales Manager. Before that, he worked as a Sales Technician at DAISA.

Turbo Energy S.A. (NASDAQ: TURB), closed Monday's trading session at $1.195, off by 5.1587%, on 5,360 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.855/$7.90.

Recent News

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.

Subsidiaries

Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Monday's trading session at $8.0808, up 5.4921%, on 3,306 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.00/$15.11.

Recent News

Vision Marine Technologies Inc. (NASDAQ: VMAR)

The QualityStocks Daily Newsletter would like to spotlight Vision Marine Technologies Inc. (NASDAQ: VMAR).

Vision Marine Technologies Inc. (NASDAQ: VMAR) is a global leader and innovator within the performance electric recreational boating industry. The company is engaged in designing and manufacturing electric outboard powertrain systems and related technology. It strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution by disrupting the traditional boating industry with electric power, in turn directly contributing to zero pollution, zero emission and a noiseless environment.

Vision Marine manufactures hand-crafted, highly durable, low maintenance, environmentally friendly electric recreational powerboats. The company’s business segments include the sale and rental of electric boats, with the majority of its revenue attributable to electric boat sales.

The designs and technology applied to Vision Marine’s boats result in enhanced performance, higher speeds and longer range. Put simply, Vision Marine boats offer a smoother ride than a traditional internal combustion engine motorboat.

The company is headquartered in Montreal.

Products

Vision Marine’s flagship E-Motion™ 180E electric marine powertrain is the first fully electric outboard powertrain combining advanced battery pack, inverter and high efficiency motor with proprietary union assembly between the transmission and motor. Vision Marine’s E-Motion and related technologies in this system utilize extensive control software and are uniquely designed to improve the efficiency of the outboard powertrain. As a result, both range and performance are enhanced.

More than a powerful electric outboard motor, the 180E is a complete powertrain package. The high-tech, marine-specific motor is equipped with multi-sensor captors and independent cooling, providing 180 horsepower.

An onboard charging system allows for quick and easy charging from any shore outlet, whether the vessel is in or out of the water. It implements cutting-edge marine battery packs that are IP67 certified and built to withstand the harshest marine environments. The system is glycol cooled with a controlled heat exchanger, ensuring optimal performance and longevity. A stainless-steel casing protects the battery from corrosion and physical damage over time.

The 180E is built to be integrated with many boat models produced by other marine manufacturers. Since boat manufacturers rarely build their own engines, instead choosing to source them from engine manufacturers, Vision Marine believes the 180E propulsion system can in the future end up powering nearly every recreational boat.

Market Opportunity

According to a report from Future Market Insights, a certified market research organization, the global electric boats market is expected to grow from a value of $5.6 billion in 2023 to $15.1 billion by 2033, achieving a CAGR of 10.4% during the forecast period.

Factors driving growth include rising seaborne commerce activities, a flourishing marine tourism industry and stringent emissions regulations aimed at reducing pollution. In addition, government support for electric speedboat adoption, advances in technological development and research and forecast expansion of needed charging infrastructure are credited as growth drivers.

An emphasis on reducing carbon emissions and encouraging consumer adoption of eco-friendly boats is also likely to drive expansion of the market, the report states.

Management Team

Alexandre Mongeon is Co-Founder and CEO of Vision Marine Technologies. He has served as CEO since 2014. Prior to that, he imported high-performance boats from the United States to Canada for more than 15 years. During much of that time, he also worked as a designer and contractor and managed several new construction projects on the waterfront in and around Montreal. He is a graduate of the School of Construction in Laval, Quebec, with a specialization in electrical systems.

Xavier Montagne is Chief Technical Officer at Vision Marine. Prior to joining the company, he was the CEO of Mac Engineering for six years. While there, he was the electric powerline architect of the Renault Trezor concept car (awarded 2016 Best Concept Car), technical designer of the Zoe E-sport race car driven in Formula-E races from 2016-2019 and senior battery designer for Forsee Power, SAFT, Renault and Peugeot in Europe, to mention a few of the many projects he headed. He received an electronic engineer diploma from IFITEP Paris Polytech in France.

Kulwant Sandher is CFO at Vision Marine. He is a Chartered Professional Accountant with more than 25 years of experience in business and finance. He has served as CFO of multiple public and private companies, including ElectraMeccanica Vehicles Corp., MineSense Technologies Inc., Alba Mineral Ltd., Delta Oil & Gas, Astorius Resources Ltd., Norsemont Mining Inc. and Intigold Mines Ltd. He graduated from Queen Mary College, University of London.

Vision Marine Technologies Inc. (NASDAQ: VMAR), closed Monday's trading session at $0.73, off by 2.8997%, on 80,044 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.69/$5.60.

Recent News

Mountain Top Properties Inc. (OTC: MTPP)

The QualityStocks Daily Newsletter would like to spotlight Mountain Top Properties Inc. (OTC: MTPP).

Mountain Top Properties Inc. (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment.

Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in Sag Harbor, New York.

Organization

The company’s flagship subsidiary is Mountain Top Realty Inc., the managing partner of its first real estate fund focused on residential redevelopment in the prestigious and storied Hamptons, New York, beachfront communities.

Mountain Top Properties is also the lead investor in blockchain-enabled industrial and warehouse flex space HQXpress, which services the warehousing, reverse logistics and liquidation markets.

The company is in negotiations for the addition of AI-powered technologies that promise to simplify real estate services, including purchasing and sales.

Mountain Top Capital Fund I LLC

Mountain Top Capital Fund I LLC is a New York limited liability company recently organized by affiliates of Mountain Top Realty, manager of the fund. Through this fund, Mountain Top Realty will leverage the company’s experience, market conditions and industry relationships to capitalize on real estate projects as they arise.

This partnership will be focused on waterfront or water view properties in the Hamptons. The Hamptons market has historically remained strong and continues to set new highs year over year.

The fund has partnered with On Site Builder Construction Co. Inc., which is managed by Joseph Kelley, who, for over 40 years, has continued to build the highest quality architecturally designed custom houses, varying in style from classic to ultra-modern, in the Hamptons. Several houses he has built are showcased in books and magazines and featured across various forms of digital and social media. His assembled team of skilled subcontractors are among the finest skilled craftsmen in their various fields of expertise.

Mr. Kelley has built over 60 custom homes in this market and has the unique distinction of building the most expensive house sold in Sag Harbor in 2014, which sold for $31,750,000; the most expensive house in the Hamptons in 2019, which first sold for $27,500,000 in 2017 and later was renovated and re-traded for $39,250,000; and the most expensive house sold in the Hamptons in 2022, which sold with the neighboring house for $118,500,000. Mr. Kelley’s portfolio of projects is valued at over $400,000,000. Although he has historically worked as a custom home builder, he would like to shift from providing a service to now providing a finished product in this market.

Market Opportunity

Mountain Top Capital Fund I has a target to raise $75 million to acquire, renovate and remarket Hamptons waterfront or water view properties. The fund has secured debt capital commitments for 70% of the acquisition costs and 100% of the construction costs and will use $10 million to leverage strategic waterfront opportunities in and around the Hamptons.

Profits from each project will be distributed upon the sale of the project, which is anticipated every 15 to 18 months, with a target of a minimum return on investment of 20% to 30% per transaction.

The company anticipates the fund’s Hamptons projects will be followed up by several other funds targeting additional high-end markets.

Management Team

Beau Kelley is CEO, President, CFO and Director of Mountain Top Properties.

Mountain Top Properties Inc. (OTC: MTPP), closed Monday's trading session at $0.0579, up 1.7575%, on 8,100 volume. The average volume for the last 3 months is 5,970 and the stock's 52-week low/high is $0.0085/$0.1898.

Recent News

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF)

The QualityStocks Daily Newsletter would like to spotlight Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF).

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) is a mineral exploration company focused on exploration activities at its newly acquired Cachoeirinha rare earths project (“PCH Project”) in Brazil, as well as delineating high-grade critical rare earth elements (REE) and gallium at its Alces Lake property in Saskatchewan. Other properties in Appia’s portfolio include its Elliot Lake Property in Ontario’s historic mining camp, with a large NI 43-101 uranium and rare earths resource. Fully funded with over $5 million (CDN) in cash, no debt, aggressive exploration currently underway, and experienced management, Appia is progressing rapidly on multiple fronts in highly desired market sectors.

The company is headquartered in Toronto, Canada.

Projects

PCH Project-Brazil

The PCH project hosts REE mineralization in both ionic clays developed from the weathering of alkaline granites and in-situ rare earth mineralization associated with the underlying granite and a carbonatite intrusion to depths greater than 100 meters. Sampling data shows enrichment in rare earth minerals to depths of between eight meters and +30 meters.

In early 2023, Appia announced a definitive agreement to acquire a 70% interest in the PCH Project, which is 17,551 hectares in size and located in the Tocantins Structural Province of the Brasília Fold Belt, Goiás State, Brazil. It is classified as an alkaline intrusive rock occurrence with the potential for highly anomalous REE and Niobium mineralization.

The region around Iporá, a city located roughly 30 km from the PCH Project, has significant mineral exploration and mining activity and well-developed infrastructure.

In July 2023, Appia commenced an aggressive auger and reverse circulation (RC) drill campaign to delineate a potential resource estimate at the PCH project. Initial results at the site revealed significant exploration potential with impressive values that often surpass known ionic clay deposits in Brazil, particularly for the highly valuable heavy rare earths Terbium and Dysprosium.

The auger holes drilled at Target 4 have exhibited a range of total REE grades, ranging from 274 ppm to 16,648 ppm (1.66%), with an average of 1,291 ppm total REE. The valuable rare earths used in magnet applications – praseodymium, neodymium, terbium and dysprosium (Pr, Nd, Tb, and Dy) plus yttrium (Y) accounted for approximately 14% of total rare earths, reaching a maximum of 28.4%. Notably, the deposit also contains anomalous values of niobium and scandium, with average values of 736 ppm for Nb and 62 ppm for scandium in a composite sample from Target 4.

Heavy rare earths (HREEs) show maximum values of 1,624 ppm and average values of 1,291 ppm, primarily as terbium and dysprosium. Light rare earths (LREEs) show maximum values of 14,024 ppm (1.54%) with an average of 1,145 ppm. Neodymium and praseodymium, the main magnetic light rare earths, show respective maximum values of 3,131 ppm (Nd) and 885 ppm (Pr) and average values of 216 ppm (Nd) and 61.7 ppm (Pr). The overall HRRE/LREE ratio has a maximum of 39.5% and an average value of 16.67%.

“Appia is thrilled with the progress made and the promising results thus far,” CEO Tom Drivas stated in a news release. “The company remains committed to advancing its exploration plans, aiming to promptly gather significant data throughout the year, and to work towards estimating a maiden mineral resource in the coming months.”

Alces Lake Project – Saskatchewan

Appia’s Alces Lake project, located in northern Saskatchewan, encompasses some of the highest-grade total and critical REEs and gallium mineralization in the world, hosted within several surface and near-surface monazite occurrences that remain open at depth and along strike.

Following the company’s acquisition of additional new mineral claims in the area in February 2023, Appia’s Alces Lake claim block now totals 38,522 contiguous hectares (95,191 acres) – 100% owned by the Company.

Appia announced the completion of a NI43-101 technical report on the property in June 2023, providing an update on exploration previously reported in March 2021.The report is available on SEDAR under the company’s profile.

Extensive diamond drilling and geophysics surveys are underway to explore a more than 25-kilometer structural corridor. In July 2023, the company issued an update on its diamond drill program having completed the first phase of drilling at the project’s Magnet Ridge Zone to further test the extent of the mineralization to the south south-east (SSE). President Stephen Burega noted the presence of “continued mineralization at significantly thicker intercepts.”

As part of its 2023 exploration program at Alces Lake, Appia plans to target priority areas that extend SSE from the Wilson, Richard, Charles, Bell, Ivan, Dylan, Dante and AMP zones through the Magnet Ridge Zone and beyond, covering an area extending approximately 20 kilometers in length and 5 to 7 km in width. Appia will also undertake reconnaissance drilling on priority regional geological and geophysical targets in the Western Anomaly area.

Other Projects

  • Appia holds a total of 75,314 hectares (186,106 acres) of land on four uranium claim blocks in the prolific Athabasca Basin (Loranger, North Wollaston, Eastside and Otherside). Exploration plans for these properties are expected to be announced once permits are in hand.
  • Appia also has a 100% interest in 12,545 hectares (31,000 acres), with rare earth element and uranium deposits over five mineralized zones, in the Elliot Lake Camp, Ontario.

Market Opportunity

A report from Mordor Intelligence forecasts the global REE market is expected to grow from 168 million tons in 2023 to 206.25 million tons by 2028, marking a CAGR of 4.19% during the forecast period. The market is gradually improving following the economic and production restrictions of the COVID-19 pandemic.

Factors driving the market’s growth include high demand from emerging economies and the dependency of environmentally friendly technologies on rare earth elements.

According to UxC, one of the nuclear industry’s leading market research and analysis companies, the uranium market is rapidly becoming production-driven, where spot and long-term prices more closely correlate to the marginal cost of uranium production.

Although global reactor requirements are projected to be flat through 2024, UxC forecasts that significant demand growth from 2025 to 2040 will necessitate new production as resources are exhausted at several uranium projects. In addition, a large percentage of production exists in regions of the world with high geopolitical risk, which makes the market vulnerable to future disruptions and price volatility.

Management Team

Tom Drivas is CEO of Appia Rare Earths & Uranium Corp. He is an entrepreneur with over 30 years of experience in various industries, including over 20 years in the mineral resource industry. He is also currently a director of Romios Gold Resources Inc., a publicly traded company he founded in 1995.

Stephen Burega is President of Appia. He brings 16 years of management and operations experience in the mining and natural resources sectors. His extensive emerging markets background, along with a deep understanding of stakeholder management, social development and structured community engagement, position him well to lead Appia’s First Nations community engagements. He is also President and CEO of Romios Gold Resources which is focused on base and precious metal exploration in North America.

Frank van de Water is the company’s CFO. He holds CPA and CA designations and has been involved with international mining, metals and resource companies in North America, Latin America, Europe and Africa for more than 40 years.

Dr. Irvine R. Annesley, Ph.D., is VP Exploration at Appia. He is a licensed geoscientist (P.GEO.) and Professor in Economic (Mining and Mineral Exploration) Geology at École Nationale Supérieure de Géologie in France and an Adjunct Professor in Geology at the University of Saskatchewan. He has over 35 years of global exploration and applied research experience in uranium, gold and base metals exploration, most recently with Athabasca uranium explorer JNR Resources Inc.

Don Hains, P.Geo., is the company’s Consulting Geologist and Qualified Person Consulting Industrial Minerals Expert.

Antonio Vitor is Appia’s Country Manager, Brazil. He has a track record as a portfolio manager and board member. He has held multiple significant positions, including Territory Manager at Shell, as well as Senior Project Planning and Consulting roles at PwC and Petrobras.

Jack Lifton is the company’s Senior Technical Advisor and Consultant. He is an author and lecturer on the market fundamentals of technology metals.

Appia Rare Earths & Uranium Corp. (OTCQX: APAAF), closed Monday's trading session at $0.11, up 1.1029%, on 220,486 volume. The average volume for the last 3 months is 169,353 and the stock's 52-week low/high is $0.075/$0.2224.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Monday's trading session at $4.7, up 11.1085%, on 296,876 volume. The average volume for the last 3 months is 70,965 and the stock's 52-week low/high is $3.8797/$46.00.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

370 N. Hayden Rd.
Suite 123-591
Scottsdale, AZ 85251
480-374-1336

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .